|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 69.05 EUR | -1.57% |
|
-5.93% | -37.40% |
| 06-09 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
| 06-04 | What Bundibugyo Ebola vaccines and treatments are under development | RE |
Main competitors
| Capi.($) | Investor | ESG MSCI | Fundamentals | Financial revisions | Global Valuation | Visibility | Consensus | ||
|---|---|---|---|---|---|---|---|---|---|
| 9.56B | A | ||||||||
| 17.33B | - | AA | - | - | |||||
| 6.53B | A | - | |||||||
| 4.91B | BBB | ||||||||
| 4.85B | - | ||||||||
| 4.29B | BBB | ||||||||
| 4.01B | - | - | - | - | - | - | - | ||
| 3.7B | - | BBB | - | - | |||||
| 2.56B | CCC | - | |||||||
| 1.37B | A | ||||||||
| 1.3B | - | - | - | - | |||||
| 1.25B | - | - | - | - | - | - | |||
| 1.24B | - | - | |||||||
| 1.12B | - | - | - | - | - | - | - | ||
| 1.11B | - | - | - | - | - | ||||
| 1.04B | - | - | - | - | - | - | |||
| 993M | - | - | - | - | - | ||||
| 970M | - | ||||||||
| 928M | - | - | - | - | - | ||||
| 895M | - | - | - | - | - | - | - | ||
| Average | 3.5B | A | |||||||
| Weighted average by Cap. | A |
- Stock Market
- Stocks
- BIM Stock
- Sector bioMérieux
- Sector ratings
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















